Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 22,100 LENZ shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 22,100 | n/a |
| Jun 8, 2026 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Jun 5, 2026 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 35,500 | n/a |
| Jun 11, 2025 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 13,500 | n/a |
| Jun 5, 2025 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 12,800 | n/a |
| Jun 5, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 40,000 | n/a |
| Apr 1, 2025 | Climb Bio, Inc. (CLYM) | Grant/Award | 80,000 | n/a |
| Jun 10, 2024 | Acumen Pharmaceuticals, Inc. (ABOS) | Grant/Award | 25,000 | n/a |
| Mar 26, 2024 | LENZ Therapeutics, Inc. (LENZ) | Grant/Award | 27,000 | n/a |
| Aug 2, 2023 | Graphite Bio, Inc. (GRPH) | Grant/Award | 40,000 | n/a |